SCHEMBL2851886

SCHEMBL2851886

CC[C@@](Cc1ccc(-c2cccc(N(C)C(=O)Nc3ccc(N(C)C)cc3)c2)cc1)(Nc1ccccc1C(=O)c1ccccc1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNPLA2 Q96AD5 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
SENP1 Q9P0U3 2/20 0.38
BDKRB1 P46663 1/20 0.38
PPARG P37231 2/20 0.38
NR1H4 Q96RI1 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNK3 O14649 1/20 0.33
CTNNB1 P35222 1/20 0.33
TCF7L2 Q9NQB0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2847841 0.84 LTB4R2 (0.38) PPARGALDH1A1
SCHEMBL2856176 0.81 PPARG (0.59) PPARGMEN1CYP3A4CYP2D6MAPT
SCHEMBL2856164 0.81 PPARG (0.59) PPARGMEN1CYP3A4CYP2D6MAPT
SCHEMBL2855300 0.80 LTB4R2 (0.38) PPARG
SCHEMBL2851883 0.79 PPARG (0.51) SENP1PPARG
SCHEMBL2849456 0.79 LTB4R2 (0.37) PPARG
SCHEMBL2854102 0.79 LTB4R2 (0.37) PPARG
SCHEMBL2855553 0.77 PPARG (0.56) PPARGMEN1CYP3A4CYP2D6MAPT
SCHEMBL2855556 0.77 PPARG (0.56) PPARGMEN1CYP3A4CYP2D6MAPT
SCHEMBL2859541 0.77 LTB4R2 (0.36) PPARGNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575911-B1 BIAROMATIC COMPOUNDS WHICH ACTIVATE PPAR-GAMMA TYPE RECEPTORS AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2010-01-13 EP claimed